Suspected Pharmacologic Triggers Do Not Appear to Cause Microscopic Colitis
By Elana Gotkine HealthDay Reporter
MONDAY, July 7, 2025 -- There does not appear to be a causal relationship between most previously suspected pharmacologic triggers and the risk for microscopic colitis (MC), according to a study published online July 1 in the Annals of Internal Medicine.
Hamed Khalili, M.D., M.P.H., from Massachusetts General Hospital in Boston, and colleagues examined the potential causal effects of previously implicated medications on the risk for MC in an emulation of six target trials involving residents in Sweden aged 65 years or older between 2006 and 2017. Inverse probability weighting was used to estimate 12- and 24-month cumulative incidences and absolute risk differences for MC.
The researchers found that under all treatment strategies, the 12- and 24-month cumulative incidences of MC were less than 0.5 percent. For angiotensin-converting enzyme versus calcium-channel blocker (CCB) initiation, angiotensin-receptor blocker versus CCB initiation, nonsteroidal anti-inflammatory drug initiation versus noninitiation, proton pump inhibitor initiation versus noninitiation, and statin initiation versus noninitiation, the estimated 12-month risk differences were close to null. For selective serotonin receptor inhibitors versus mirtazapine, the estimated 12-month risk difference was 0.04 percent. For 24-month differences, the results were similar. An increased risk for receiving a colonoscopy with a normal colorectal mucosa biopsy result was seen in association with several medications.
"Our study demonstrated that, contrary to the previous belief, it's unlikely that medications are the primary triggers for microscopic colitis," Khalili said in a statement. "Clinicians should carefully balance the intended benefits of these medications against the very low likelihood that they cause microscopic colitis."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
Racialized Economic Segregation Linked to Advanced Cancer Diagnosis
FRIDAY, Aug. 1, 2025 -- People living in racially and economically segregated neighborhoods are more likely to be diagnosed with advanced-stage breast and cervical cancer...
New Subtype of Diabetes Identified in Sub-Saharan Africans, Black Americans
FRIDAY, Aug. 1, 2025 -- A new diabetes subtype has been identified in Sub-Saharan Africans and Black Americans, according to a study published online July 21 in The Lancet...
Changes in Missouri Law Linked to Increased Breast Cancer Screening Rates
THURSDAY, July 31, 2025 -- Changes in Missouri law expanding breast cancer screening coverage have led to increased screening rates among Medicaid patients and an increased...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.